Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Grayscale exec: Crypto ETFs will expand to new asset types and indices

Grayscale exec: Crypto ETFs will expand to new asset types and indices

Bitget2024/08/12 22:49

Dave Lavalle, Grayscale’s global head of ETFs, reportedly said in an August 12 webinar: “We’re going to see more single-asset products, and certainly some index-based diversified products.” Many other proposed cryptocurrency ETFs are awaiting regulatory approval. They include new types of single-asset funds, such as the Solana (SOL) ETF, and diversified cryptocurrency indices, such as the Hashdex Nasdaq Crypto Index ETF. National stock exchanges such as Nasdaq also hope to start listing BTC and ETH ETF options soon. Cryptocurrency ETFs have been in huge demand since their launch this year, partly due to adoption by large financial institutions such as Morgan Stanley.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.

The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.

智通财经2026/09/21 07:31

Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD

Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.

智通财经2026/09/21 07:16

Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.

U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).

智通财经2026/09/21 07:11